CFO4Life Group’s Hologic HOLX Stock Holding History

CFO4Life Group’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,082	Closed	-$452K	–	148
2021 Q1	$452K	Buy	6,082 +816	+15%	+$61.9K	0.11%	93
2020 Q4	$384K	Buy	+5,266	New	+$372K	0.11%	103

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CFO4Life Group's HOLX Position: Q2 2021 in Review

CFO4Life Group sold out of Hologic (HOLX) in Q2 2021, closing a stake of 6,082 shares — an estimated $452K sold.

CFO4Life Group first reported a position in HOLX in Q4 2020 and held it in 2 quarters. The position peaked at $452K in Q1 2021. 625 funds tracked by Wall St. Rank hold HOLX as of Q2 2021.

CFO4Life Group reported no remaining Hologic position as of Q2 2021 after selling out during the quarter.
CFO4Life Group sold 6,082 Hologic shares in Q2 2021, an estimated $452K.
CFO4Life Group first reported a position in Hologic in Q4 2020 and held it in 2 quarters.
CFO4Life Group's Hologic position peaked at $452K in Q1 2021.
625 funds tracked by Wall St. Rank held Hologic as of Q2 2021.

Based on CFO4Life Group's 13F filing for Q2 2021, filed 14 Jul 2021.